Linagliptin
Brand name: Tradjenta
Rank #46 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$403.8M
Total Cost
519,439
Total Claims
$403.8M
Total Cost
16,484
Prescribers
$777
Cost per Claim
39,375
Beneficiaries
818,411
30-Day Fills
$24K
Avg Cost/Provider
32
Avg Claims/Provider
Share of Medicare Part D Spending
0.15%
of total Medicare Part D spending
$403.8M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $403.8M total
🔎 Data Overview
Ranked #46 out of 500 drugs tracked by total cost. Linagliptin represents a significant portion of Medicare drug spending.
Average cost of $10,256 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Linagliptin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Sang Baik | Internal Medicine | Los Angeles, CA | 586 | $532K |
| 2 | Kelvin Mai | Internal Medicine | Santa Ana, CA | 458 | $502K |
| 3 | Matin Sharafatkhah | Endocrinology | Brooklyn, NY | 764 | $466K |
| 4 | Yin Win | Internal Medicine | New York, NY | 272 | $370K |
| 5 | Roberto Duran | Family Practice | Eagle Pass, TX | 250 | $370K |
| 6 | Armando Hinojosa | Internal Medicine | Laredo, TX | 319 | $365K |
| 7 | Hong Kim | Internal Medicine | Garden Grove, CA | 475 | $350K |
| 8 | Mary Tran | Family Practice | Garden Grove, CA | 368 | $317K |
| 9 | Duc Phan | Internal Medicine | Houston, TX | 266 | $315K |
| 10 | Mark Song | Internal Medicine | Los Angeles, CA | 320 | $298K |
| 11 | Enrique Griego | Family Practice | Mcallen, TX | 226 | $292K |
| 12 | Manuel Franco | Family Practice | Chicago, IL | 285 | $287K |
| 13 | Laurie Cochran | Family Practice | Forsyth, GA | 256 | $287K |
| 14 | Soo Kang | Internal Medicine | Buena Park, CA | 374 | $282K |
| 15 | Weiwen Zheng | Family Practice | San Francisco, CA | 189 | $282K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 43 | Osimertinib Mesylate (Tagrisso) | $436.5M | 25,273 |
| 44 | Levothyroxine Sodium (Levothyroxine Sodium) | $435.3M | 20,209,418 |
| 45 | Deutetrabenazine (Austedo) | $404.1M | 60,532 |
| 46 | Linagliptin (Tradjenta) | $403.8M | 519,439 |
| 47 | Macitentan (Opsumit) | $394.6M | 30,889 |
| 48 | Insulin Detemir (Levemir Flexpen) | $376.5M | 548,216 |
| 49 | Aripiprazole (Aripiprazole) | $373.1M | 1,494,971 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology